Fluvastatin in the therapy of acute coronary syndrome: Rationale and design of a multicenter, randomized, double-blind, placebo-controlled trial (The FACS Trial)[ISRCTN81331696]

BACKGROUND: Activation of inflammatory pathways plays an important contributory role in coronary plaque instability and subsequent rupture, which can lead to the development of acute coronary syndrome (ACS). Elevated levels of serum inflammatory markers such as C-reactive protein (CRP) represent ind...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Curr Control Trials Cardiovasc Med
Autori principali: Ostadal, Petr, Alan, David, Hajek, Petr, Vejvoda, Jiri, Mates, Martin, Blasko, Peter, Veselka, Josef, Kvapil, Milan, Kettner, Jiri, Wiendl, Martin, Aschermann, Ondrej, Slaby, Josef, Nemecek, Eduard, Holm, Frantisek, Rac, Marek, Macek, Milan, Cepova, Jana
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMC 2005
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC555952/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15790413/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1468-6708-6-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi